The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Rating of “Hold” from Brokerages

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average rating of “Hold” from the sixteen research firms that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $81.3077.

COO has been the topic of several recent research reports. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, June 1st. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a report on Wednesday, May 27th. Stifel Nicolaus cut their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Mizuho set a $85.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. Finally, Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently bought and sold shares of COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after acquiring an additional 7,363 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of Cooper Companies by 115.8% during the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after acquiring an additional 73,165 shares in the last quarter. Cresset Asset Management LLC bought a new stake in shares of Cooper Companies during the 2nd quarter worth $291,000. Cerity Partners LLC boosted its stake in shares of Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after acquiring an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after acquiring an additional 973 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 4.1%

Shares of NASDAQ:COO opened at $68.83 on Thursday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The firm has a market capitalization of $13.42 billion, a PE ratio of 58.33, a price-to-earnings-growth ratio of 1.73 and a beta of 0.87. The firm’s 50-day moving average is $64.11 and its two-hundred day moving average is $73.74. Cooper Companies has a 1 year low of $58.89 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts predict that Cooper Companies will post 4.63 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.